Log in to search using one of your social media accounts:


Combining Cataract Surgery, Baerveldt-tube Implant Sometimes Useful for Glaucoma Combining Cataract Surgery, Baerveldt-tube Implant Sometimes Useful for Glaucoma

Cataract surgery and implantation of a Baerveldt tube (BT) for glaucoma should be done separately in most cases, but may be combined in some, research from Switzerland suggests.Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Ophthalmology News Source Type: news

Related Links:

Were The Graduate's Ben Braddock to receive a one-word bit of career advice today, it might very well be "MIGS" instead of plastics. MIGS stands for minimally invasive glaucoma surgery, and both financial analysts and developers of the tiny devices designed to treat the disease expect the market to pop for the foreseeable future. "On a scale of one through 10, I would say the market is probably somewhere between one and two in terms of maturity," said Dave Van Meter, CEO of Irvine, CA-based Ivantis. "The market in the U.S. today is probably somewhere around a couple hundred million dollars, ac...
Source: MDDI - Category: Medical Devices Authors: Tags: Implants Source Type: news
Authors: Doycheva D, Deuter C, Grajewski R Abstract Topical corticosteroids are effective anti-inflammatory drugs in the treatment of anterior uveitis. The intraocular efficacy of topical corticosteroids mostly depends on their intraocular permeability through the cornea. Lipophile derivatives such as dexamethasone and prednisolone acetate penetrate better into the anterior chamber than hydrophilic derivatives. Prednisolone acetate 1% is the first choice in the therapy of patients with anterior uveitis. Loteprednole and fluorometholone have a slightly weaker anti-inflammatory effect, but they induce less elevation ...
Source: Klinische Monatsblatter fur Augenheilkunde - Category: Opthalmology Tags: Klin Monbl Augenheilkd Source Type: research
Abstract PURPOSE: To evaluate the feasibility, efficacy and safety of Ex-PRESS implantation combined with phacoemulsification surgery in primary angle-closure glaucoma (PACG) with cataract. MATERIALS AND METHODS: This is a prospective, nonrandomized study. A total of 34 eyes of 34 subjects were enrolled. The assessments were conducted preoperatively and postoperatively at 1 week and 1, 3, 6, 12, 18, 24, 30, 36 months. The assessments included intraocular pressure (IOP), best corrected visual acuity (BCVA), the number of glaucoma medications, corneal endothelial cell density (ECD) and related complic...
Source: Current Eye Research - Category: Opthalmology Authors: Tags: Curr Eye Res Source Type: research
Conclusions: To the best of our knowledge this is the largest study that has investigated the association between postoperative topical PGA or topical beta-blocker use and the incidence of pseudophakic CME. Postoperative use of both topical PGAs and topical beta-blockers was found to be associated with the incidence of pseudophakic CME.
Source: Journal of Glaucoma - Category: Opthalmology Tags: Original Studies Source Type: research
To report the long-term efficacy of endoscopic cyclophotocoagulation (ECP) in pediatric glaucoma following cataract surgery (GFCS).
Source: Journal of AAPOS - Category: Opthalmology Authors: Tags: Major Article Source Type: research
Authors: Ambroz SC, Töteberg-Harms M, Hanson JVM, Funk J, Barthelmes D, Gerth-Kahlert C Abstract Purpose: To determine and to analyze the outcome of pediatric cataract surgery. Methods: A retrospective chart review of individuals aged up to 10 years who underwent cataract surgery between January 1, 2004, and December 31, 2014, at the UniversityHospital Zurich, Switzerland. Results: 63 children (94 affected eyes) with bilateral (68/94) or unilateral (26/94) cataract were identified. Surgery was performed at a median age of 1.5 months (IQR: 1.3-2.6 months) for the aphakic group (45/94) and of 50.7 months...
Source: Journal of Ophthalmology - Category: Opthalmology Tags: J Ophthalmol Source Type: research
Johnson &Johnson (NYSE:JNJ) saw its vision care sales grow 34% last quarter over its previous first quarter as it looks to significantly grow the business into the surgical and device segments, according to a CNBC report. The company added a number of surgical products alongside a contact subscription service, which come in addition to its existing popular Acuvue contact lens line, according to the report. The investment has seen a significant return for the company, becoming one of its fastest-growing platforms. Johnson &Johnson only began investing in eye surgery two years ago after announcing it would acqui...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Optical/Ophthalmic Wall Street Beat johnsonandjohnson Source Type: news
CONCLUSIONS: Patients with high hyperopia often have ocular comorbidities. Such eyes may be surgically challenging, resulting in reduced benefits from cataract surgery compared to normal eyes. PMID: 29669369 [PubMed - in process]
Source: Klinische Monatsblatter fur Augenheilkunde - Category: Opthalmology Tags: Klin Monbl Augenheilkd Source Type: research
This study looks at the viability of MIGS in patients who don’t need or may have already had cataract surgery, so it’s a vital addition to our growing body of evidence supporting MIGS,” Compare trial medical monitor Dr. Iqbal Ahmed said in a prepared release. Ivantis said the 152-patient trial was the first to compare two minimally invasive glaucoma surgery device for treating open-angle glaucoma in a standalone procedure. The study aimed to compare safety and effectiveness of both devices in lowering IOP and reducing eye-drop medication. Results at one year showed that 47% of eyes treated with the Hydrus...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Optical/Ophthalmic Glaukos Ivantis Source Type: news
Glaukos (NYSE:GKOS) today released two-year data from the FDA investigational device exemption pivotal trial of its iStent inject trabecular micro-bypass system, and announced a patent infringement suit it filed against Ivantis. Results of the 505-patient study were presented at the American Society of Cataracts and Refractive Surgery annual meeting by Dr. Thomas Samuelson of the Minnesota Eye Consultants, the San Clemente, Calif.-based company said. The iStent inject trabecular micro-bypass system is designed to treat mild-to-moderate open-angle glaucoma in patients undergoing cataract surgery. It uses a pa...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Optical/Ophthalmic Patent Infringement Glaukos Source Type: news
More News: Cataract Removal | Cataracts | Glaucoma | Opthalmology | Surgery | Switzerland Health